PSA-Screening in Schweden: Deutlich geringere Prostatakarzinom-Mortalität

[Article in German]

No authors listed

Comment

[Article in German]

No authors listed. Aktuelle Urol. 2023 Feb.

. 2023 Feb;54(1):10.

doi: 10.1055/a-1925-4156. Epub 2023 Feb 14.

No abstract available

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Kommentar zu PSA-Screening in Schweden: Deutlich geringere Prostatakarzinom-Mortalität.
[No authors listed] [No authors listed] Aktuelle Urol. 2023 Feb;54(1):10-12. doi: 10.1055/a-1891-7312. Epub 2023 Feb 14. Aktuelle Urol. 2023. PMID: 36787766 German. No abstract available.

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial.
Frånlund M, Månsson M, Godtman RA, Aus G, Holmberg E, Kollberg KS, Lodding P, Pihl CG, Stranne J, Lilja H, Hugosson J. Frånlund M, et al. J Urol. 2022 Aug;208(2):292-300. doi: 10.1097/JU.0000000000002696. Epub 2022 Apr 15. J Urol. 2022. PMID: 35422134 Free PMC article. Clinical Trial.